Taewoong Choi

Taewoong Choi

Hematology Oncology | Hematology | Transplant Surgery

2400 Pratt St
Durham, NC 27705

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study.

Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study.

Journal: Open forum infectious diseases

Published: February 19, 2026

Respiratory Viral Infections Following CD19 CAR T-Cell Therapy.

Respiratory Viral Infections Following CD19 CAR T-Cell Therapy.

Journal: Journal of medical virology

Published: January 20, 2026

Sociodemographic factors and timing of allogeneic hematopoietic stem cell transplantation in myeloproliferative neoplasms.

Sociodemographic factors and timing of allogeneic hematopoietic stem cell transplantation in myeloproliferative neoplasms.

Journal: Bone marrow transplantation

Published: December 08, 2025

Musculoskeletal Adverse Events Following BCMA CAR T-Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates.

Musculoskeletal Adverse Events Following BCMA CAR T-Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates.

Journal: Transplantation and cellular therapy

Published: November 05, 2025

Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel.

Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel.

Journal: British journal of haematology

Published: August 25, 2025

Impact of donor age on cognitive recovery in allogenic hematopoietic stem cell transplant patients with mild cognitive impairment.

Impact of donor age on cognitive recovery in allogenic hematopoietic stem cell transplant patients with mild cognitive impairment.

Journal: Bone marrow transplantation

Published: August 13, 2025

Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative Study.

Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative Study.

Journal: Transplantation and cellular therapy

Published: June 27, 2025

A retrospective study on beta-blocker use and outcomes in hematopoietic stem cell transplant patients.

A retrospective study on beta-blocker use and outcomes in hematopoietic stem cell transplant patients.

Journal: PeerJ

Published: November 12, 2024

Food insecurity prior to hematopoietic stem cell transplant is associated with malnutrition and worse outcomes.

Food insecurity prior to hematopoietic stem cell transplant is associated with malnutrition and worse outcomes.

Journal: Bone marrow transplantation

Published: August 09, 2024

Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantation.

Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantation.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: May 16, 2024

Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis.

Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis.

Journal: JCO oncology practice

Published: December 21, 2023

A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.

A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.

Journal: Transplantation and cellular therapy

Published: September 10, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026